Cancer Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Bladder Cancer
Reports from Osaka Medical College, Medical College add new data to research in bladder cancer
April 1st, 2008
"We tested the usefulness of combined therapy using balloon-occluded arterial infusion (BOAI) of cisplatin and hemodialysis, which delivers an extremely high concentration of cisplatin to the site of a tumor without systemic adverse effects, with concurrent radiation in patients with locally advanced bladder cancer. Patients underwent transurethral resection of the bladder tumor followed by BOAI of cisplatin (100, 200, or 300 mg) concurrent with hemodialysis, via both common iliac veins, for 2 hours after initiation of BOAT," scientists in Takatsuki, Japan report. "A total of 60.4 Gy of radiation was delivered, starting from the day of BOAI. Forty-one patients (30 males...
Source: Cancer Weekly (2008-04-01)
|
